SK

Supriya Kumar

Active Director Director DIN 08161043
DIN 08161043 First appointment Jun 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2018
Shareholding value •••• Premium profile

About Supriya Kumar

Data last updated:

Supriya Kumar is a Director at Suhabi Biotech Private Limited (since 2018). The company operates in Trading. Suhabi Biotech Private Limited reported revenue of ₹5.1 Lakh (FY 2025).

DIN 08161043
Primary Designation Director
Industry Trading
First Appointment 19 Jun 2018
Oldest Company Age 8 yrs
Largest company Suhabi Biotech Private Limited · ₹5.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Suhabi Biotech Private Limited U51909BR2018PTC038512
Director19 Jun 20182018₹5.1 Lakh (FY 2025)Active

Board colleagues of Supriya Kumar

NameDINCompanyDesignation
Ruby Kumari08161044Suhabi Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Suhabi Biotech Private Limited
Premium access

Shareholding and investment profile for Supriya Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Supriya Kumar

Supriya Kumar currently holds 1 directorship: Suhabi Biotech Private Limited (Director, since 19 Jun 2018, revenue ₹5.1 Lakh (FY 2025)).

Supriya Kumar was first appointed on 19 Jun 2018 as Director at Suhabi Biotech Private Limited.

The current boards of Supriya Kumar's companies include Ruby Kumari (Suhabi Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available